2101

· Response Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 2101, covering 2023-11-18 to 2023-11-18. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, and Pharmacodynamic Profile of Oral 2101 in Secondary Raynaud's Disease [Phase 2]